Why is Metropolis Healthcare Ltd ?
1
High Management Efficiency with a high ROE of 16.21%
2
Company has a low Debt to Equity ratio (avg) at 0.08 times
3
Poor long term growth as Net Sales has grown by an annual rate of 11.48% and Operating profit at 3.94% over the last 5 years
4
Positive results in Sep 25
- OPERATING CF(Y) Highest at Rs 275.01 Cr
- OPERATING PROFIT TO INTEREST(Q) Highest at 19.05 times
- NET SALES(Q) Highest at Rs 429.19 cr
5
With ROE of 11, it has a Expensive valuation with a 7.1 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -8.90%, its profits have risen by 6.9% ; the PEG ratio of the company is 11.4
6
High Institutional Holdings at 45.62%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
7
Below par performance in long term as well as near term
- Along with generating -8.90% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Healthcare Services)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Metropolis Healt for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Metropolis Healt
9.42%
-0.29
30.48%
Sensex
-4.3%
0.44
11.83%
Quality key factors
Factor
Value
Sales Growth (5y)
11.40%
EBIT Growth (5y)
3.16%
EBIT to Interest (avg)
11.23
Debt to EBITDA (avg)
0.72
Net Debt to Equity (avg)
0.08
Sales to Capital Employed (avg)
0.98
Tax Ratio
24.84%
Dividend Payout Ratio
16.03%
Pledged Shares
1.18%
Institutional Holding
46.42%
ROCE (avg)
28.03%
ROE (avg)
16.21%
Valuation Key Factors 
Factor
Value
P/E Ratio
50
Industry P/E
55
Price to Book Value
6.13
EV to EBIT
38.46
EV to EBITDA
25.06
EV to Capital Employed
5.73
EV to Sales
5.68
PEG Ratio
3.67
Dividend Yield
0.24%
ROCE (Latest)
13.69%
ROE (Latest)
11.05%
Loading Valuation Snapshot...
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Movement
15What is working for the Company
NET SALES(Latest six months)
At Rs 835.10 cr has Grown at 24.17%
DEBT-EQUITY RATIO(HY)
Lowest at 0.14 times
PAT(Q)
At Rs 48.09 cr has Grown at 21.6% (vs previous 4Q average
-2What is not working for the Company
DEBTORS TURNOVER RATIO(HY)
Lowest at 8.42 times
Loading Valuation Snapshot...
Here's what is working for Metropolis Healt
Net Sales - Latest six months
At Rs 835.10 cr has Grown at 24.17%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Debt-Equity Ratio - Half Yearly
Lowest at 0.14 times and Fallen
each half year in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Profit After Tax (PAT) - Quarterly
At Rs 48.09 cr has Grown at 21.6% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 39.56 CrMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Here's what is not working for Metropolis Healt
Debtors Turnover Ratio- Half Yearly
Lowest at 8.42 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
Non Operating Income - Quarterly
Highest at Rs 9.02 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income